She reported that the blurriness was in both eyes, and it was slowly progressive over the past few months. She had a medical history of high blood pressure, high cholesterol, and rheumatoid arthritis. Hydroxychloroquine medical definition Plaquenil 200 mg sanofi aventis Chloroquine injection drug interactions Chloroquine aralen price To study the incidences of and risk factors for chloroquine CQ and hydroxychloroquine HCQ retinopathy in Thai rheumatologic patients. A retrospective cohort study of 234 rheumatologic patients receiving either CQ or HCQ was conducted. Patients were. One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine Plaquenil, a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. The risk factors detailed below are recognised to increase the risk of HCQ retinopathy. The sum of risk factors can provide an estimation of risk for a given individual. 40 Some risk factors are. Her visual acuity with habitual Rx at distance was 20/40 OD and 20/50-OS, while at near was 20/40. She was currently taking 81 mg aspirin, atorvastin (Lipitor, Pfizer), Centrum Silver multivitamin, fish oil, hydroxychloroquine (Plaquenil, Concordia) 200 mg QD, isosorbide mononitrate (Imdur, Hikma), levetiracetam (Keppra, Pfizer), Nitrostat (nitroglycerin, Pfizer), Restasis (cyclosporin, Allergan), Ranexa (ranolazine, Gilead), Trexall (methotrexate, Teva), citalopram (Celexa, Forest Labs), losartan/hydrochlorothiazide (Hyzaar, Merck), sulfamethoxazole/trimethoprim (Bactrim DS and topiramate (Trokendi XR, Ortho-Mc Neil). Hydroxychloroquine retinopathy risk Hydroxychloroquine blood levels predict retinopathy risk in lupus, Hydroxychloroquine-Induced Retinal Toxicity - American. Medication likely administered with chloroquine for amebiasis This is the first study that focuses on assessing retinopathy risk by tracking hydroxychloroquine blood levels. Despite the benefits of treatment, which may also include anti-thrombotic and anti-diabetic effects and complete renal remission when given in combination with mycophenolate mofetil, the risks have been well documented. Retinopathy Risk in Lupus Increases With Longer.. Hydroxychloroquine retinopathy Eye. Hydroxychloroquine toxicity - EyeWiki. May 16, 2011 Hydroxychloroquine Plaquenil; HCQ has been an important and effective drug for the treatment of lupus erythematosus and related autoimmune and inflammatory diseases for half a century, although its potential to cause retinal damage continues to raise concern among rheumatologists and ophthalmologists. Risk of HCQ toxicity was then assessed in tertiles defined by these variables. The duration of hydroxychloroquine use years in tertiles by distribution and its association with HCQ toxicity were also examined. Results The risk of HCQ toxicity is shown in Table 1. Table 1. Risk of HCQ retinal toxicity by variable. Managing the complications of hydroxychloroquine retinopathy is an evolving process driven by research papers such as this. The risk is increased for patients taking more than 5 mg/kg/day.